BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-09-19

Reporting Person: Davis George Eric (SVP, General Counsel)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-19	Common Stock	M	17536	$21.51	Acquired	81962	Direct
2014-09-19	Common Stock	S	17536	$69.75	Disposed	64426	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-19	Stock Option (right to buy) Common Stock	$69.75	M	17536	Acquired	2020-05-11	Common Stock (17536)	Direct

F1: Transaction made pusuant to a Rule 10b5-1 trading place executed on August 25, 2014..

F2: All shares sold at same price.

F3: Original option grant vests 6/48ths on November 12, 2010 and 1/48th on the 12th day of every month thereafter

F4: Reflects the number of stock options that reaming outstanding from this specific stock option grant following the reported transaction.